CLINICAL_TRIALS
trial_result
· 2012-02-10
Clinical Trial Update: Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children. [Phase 3]
Summary
Phase 3 study evaluating the impact of the 13-valent pneumococcal conjugate vaccine in Alaskan Native children; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pneumococcal Disease, 13-valent Pneumococcal Vaccine | Phase 3 | Status: COMPLETED | Results posted: 2012-02-10